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ABSTRACT
Ticks have been recognized as harmful parasite since ancient times. At present immunological protection of host
against ticks is the most practical and sustainable tick control method, which is more suitable to natural environment compared
to the current use of acaricides. Recently, focuses on the development of anti-tick vaccine are the identification, molecular
cloning and in vitro production of recombinant protein, responsible for executing key roles in regulating physiology, modulation
of host immune response and pathogen transmission via ticks. Among several works, serine protease inhibitors have been
thought as one of the most interest vaccine candidates, because serine protease inhibitors are mainly involved in the mainte-
nance of homeostasis. In the current review, we would like to introduce selected examples covering aspects of tick vaccine
antigen identification and analyses, because advances in vector molecular biology open new possibilities for vaccine develop-
ment. In dealing with this subject, contents were mainly divided into tick salivary gland associated molecules (exposed antigens)
injected into the host during tick feeding and no salivary gland molecules (concealed antigens). While emerging the fact that
serine protease inhibitors belong to either exposed or concealed antigens, the utility of serine protease inhibitors for the candidate
vaccine have been discussed separately because of the importance of serine protease inhibitors in the physiology of several
organisms including ticks. Advances in tick vaccine development and related subjects are regularly reviewed and in this paper,
referred citations of excellence are suggested as additional reading.
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RESUMO
Os carrapatos têm sido reconhecidos como parasitos nocivos desde os remotos tempos. A proteção imunológica é
o método de controle o mais prático e sustentável para controle do carrapato, pois é mais apropriada ao meio ambiente do que o
uso de acaricidas. Atualmente, os focos no desenvolvimento de vacina contra carrapato são a identificação, a clonagem e a pro-
dução in vitro de proteínas recombinantes que apresentem funções importantes na fisiologia do carrapato, na modulação da
resposta imune do hospedeiro e na transmissão de patógenos pelos carrapatos. Entre diversos alvos, os inibidores de serino-
proteases são um dos mais interessantes candidatos, pois estão envolvidos manutenção da homeostasia do carrapato. Na pre-
sente revisão, serão apresentados alguns exemplos selecionados que enfocam aspectos da identificação e de análises de antígenos
vacinais, pois os avanços na biologia molecular do vetor permitem novas possibilidades para o desenvolvimento de vacinas.
Dentro deste tópico, o texto foi dividido, principalmente, nas moléculas associadas à glândula salivar (antígenos expostos -
que são inoculados no hospedeiro durante uma infestação natural) e, em moléculas não presentes na glândula salivar (antígenos
ocultos). Mesmo, sendo os inibidores de serino-proteases antígenos expostos e/ou ocultos, o uso de inibidores de serino-proteases
foi discutido separadamente por causa da sua importância na fisiologia de diferentes organismos, incluindo os carrapatos. Os
avanços no desenvolvimento de vacinas contra carrapato e tópicos relacionados são regularmente alvos de revisões. Neste
trabalho são referenciadas excelentes contribuições sugeridas como leitura adicional.
Descritores: carrapato, vacina, immunização, serpina, Boophilus microplus, Haemaphysalis longicornis.
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I. INTRODUCTION
Ticks have been recognized as harmful para-
site since ancient times. While ticks are also important
as vectors of pests, they are mostly known for their
roles as vectors, particularly of animals [69,74]. Ticks
surpass all other arthropods in the number of and va-
riety of pathogens which they can transmit to domes-
tic animals, and are ranked 2nd next to mosquitoes
as vectors of human diseases [56,69]. Ticks affect live-
stock production as described below either through
their role as vectors of disease or by their feeding acti-
vities. For examples, losses due to direct tick feeding re-
sult in loss of weight, damaged hides, reduced milk pro-
duction. In the estimation by Norval et al. [54], weight
loss in cattle is estimated as 4.4 grams per Rhipicephalus
appendiculatus female and 10 grams per Amblyomma
haebraeum female. The annual global cost of control-
ling ticks and tick borne diseases, together with the
reduced livestock productivity amounts to billion of
dollars, though the precise figures for most countries
are insufficient [16]. According to an estimate by Sur-
therst et al [71], ticks affect approximately 800 million
cattle and a similar number of sheep world-wide, and
monetary losses due to tick borne diseases alone on
the cattle industry were estimated at approximately US$
7 billion [60]. The magnitude of the negative impact
caused by ticks on livestock production leads to neces-
sitate incorporation of several tick-control programs into
modern livestock management practices.
Advances in tick vaccine development and re-
lated subjects are regularly reviewed and the reader
is referred to excellent reviews by Tellam et al [74],
Nuttall et al [55], Mulenga et al [44], De la Fuente and
Kocan [11], Willadsen [92] and Willadsen and Jongejan
[94], for further reading.
II. CONTROL METHODS
Currently, the mainstay of the tick control me-
thod heavily relies on the use of chemical acaricides.
However, the use of acaricides is associated with a
number of disadvantages such as chemical pollution
of the food chain and environment as well as the rapid
development of resistance against acaricides by ticks
[52,74]. Especially, reducing effectiveness of acaricides
is in certain instances, because rapid development of
tick resistance to new compounds might discourage
efforts to discover new acaricides in the aspect of the
high cost for research, development and registration
[89]. In addition, this method needs consistent applica-
tion of acaricides, making the method labor intensive
and very costly, especially during the rain season in
tropical and subtropical climates. When the population
of ticks becomes peak, acaricides have to be applied
twice per week to maintain low tick populations [43].
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Failure to continue the strict application of acaricide
results in a rapid propagation of tick populations. For
instance in Zimbabwe during the liberation struggle,
tick control was suspended for 7 years, resulting in a
flare up of the Rhipicephalus appendiculatus tick popu-
lation and an increased number of theieriosis cases [53].
As taken these results into consideration, it is neces-
sary to develop alternative methods for tick control.
The alternative tick control methods have also
been considered so far and they could be divided into
3 groups, biological control of ticks by introducing
the pathogens or predators into the tick habitats, habitat
modifications by planting tick-killing or repelling vege-
tation, and immunological control of ticks [69]. Though
some of these approaches were proved effective, most
of these methods have not been continued, because
they have not been practical in tick control programs
as such apart from immunological controls of ticks
[34,57,88]. Advantages of anti-tick vaccines/immunolo-
gical tick control would include, specificity of target
species, environmental safety, absence of human health
risk, no residues in food products, ease of administra-
tion and cost [89]. Immunological protection against
tick infestation depends on the fact that host can natu-
rally develop resistance against tick feeding after repea-
ted feeding. Acquired resistance to tick infestation is
expressed as reduced engorgement weight, increased
duration of feeding, impaired production and viability
of ova, inhibition of moulting and death of feeding
ticks [87,89].
III. IMMUNOLOGY PROTECTION
As referred to Wikel [89], acquired resistance
to tick infestation was reported for the first time by
Johnston and Bancroft in 1918. They attributed the
resistance against ticks in cattle to the substances intro-
duced by ticks into the host during feeding and the
resistant cattle developed cutaneous exudates at attach-
ment sites. Experimental analysis of the basis for ac-
quired resistance to tick feeding started with the work
by Trager [75], who reported that guinea pigs develo-
ped systematic immunity after one infestation with De-
mancenteor variabilis larvae. Trager also proved that
the performance of larval ticks of D. variavilis feeding
on guinea pigs previously exposed to tick feeding was
inferior compared to those feeding on naive guinea
pigs. These observations have been confirmed by a
series of studies as reviewed by Willadsen [90] and
Opdebeeck [57]. There are several researches using
crude tick homogenates as vaccine antigens, and have
succeeded in inducing some levels of protective anti-
tick immunity warranting further studies to develop
vaccines against ticks. Though progress toward the
development of anti-tick vaccine was obstructed for
a long time by the lack of efficient methods to pro-
duce tick vaccine antigens in sufficient amounts for
immunization, it has become from a possibility to a
reality by the recent advance of molecular biological
technology [64]. One practical example towards the
development of anti-tick vaccine against 1-host tick
has been demonstrated by an Australian group, which
reported the successful development and commer-
cialization of a recombinant anti-Boophilus microplus
vaccine based upon the tick midgut-associated mole-
cule, Bm 86 [66,74,91,93]. Though these studies provi-
ded important evidence on the reliability and practica-
bility of the DNA biotechnology with respect to the
production of recombinant tick-associated antigens,
studies on other major 3-host tick species such as Hae-
maphysalis, Rhiphicephalus and Amblyomma are still
far from being practical.
Recently focus on the development of anti-
tick vaccine is the identification, molecular cloning
and in vitro production of recombinant proteins, which
could play key roles such as regulating physiology,
modulation of host immune response and transmission
of pathogens by ticks [44]. Therefore, the overall objec-
tive of the present study aimed at the identification,
cloning and expression in vitro as well as assessing
the protective efficacy of recombinant tick molecules
which could be applicable for the field conditions.
1. Characteristics of exposed and concealed antigens
Traditionally, tick molecules are categorized
into two groups [93]. The first is exposed antigens that
are secreted in tick saliva and introduced into host’s
bite site during tick attachment and feeding. There-
fore antigen derived from saliva is usually called as
exposed antigens. As these molecules are exposed to
the host by every tick feeding, acquired immunity
against exposed antigens are naturally established and
boosted by multiple feeding of ticks. Because once
host acquired immunity against exposed antigens, host
immune system reacts to those when a tick start secre-
ting the molecules into bite site. Taken the fact into
consideration, the levels of immunity induced by immu-
nization with an exposed antigen would be sustained
by every tick feeding. Especially, one such promising
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antigen is the cement protein, which is essential for
assistance in the attachment to the host skin and is
generally highly immunnogenic against host. In con-
trast, concealed antigens are not contact with host im-
mune system by the natural feeding of ticks. Though
concealed antigens do not induce immune responses
by tick feeding, they are immunogenic when they ino-
culated artificially. Therefore it could be potential
candidates for vaccine as long as the antigen encoun-
ters host immunoglobulines, entering the gut or hemo-
lymph, and is associated with some physiological
function for tick. However acquired immunity against
concealed antigen dose not boosted by natural feeding
of tick. For instance, the tick gut is representative con-
cealed antigen.
Though exposed antigens have been identi-
fied by their ability to induce an antibody response
through tick repeated infestations, existence of the
bioactive molecules in tick saliva is potential problem
for targeting exposed antigens. Namely tick saliva
play important roles in creating optimal feeding envi-
ronment and linked to the ability of pathogen transmis-
sion, these molecules are secreted into saliva to modu-
late host’s hemostatic, inflammatory and immune sys-
tem so that the tick can attach and feed successfully [8].
As a result, immunity induced by natural tick feeding
or artificial immunization of exposed antigen reduces,
and does not interfere with tick feeding even after
repeated exposure to ticks [65]. Therefore it is thought
to be difficult to induce sufficient levels of acquired
immunity with exposed antigen, particularly if only
a single exposed antigen is used to develop a vaccine.
Moreover, intensive studies on random sequencing of
tick cDNA library also supported this potential pro-
blem. Because gathering information from random se-
quencing analyses of cDNAs demonstrated that saliva
component during feeding is mainly consisted of the
bioactive molecules towards host defensive process
like blood coagulation cascade, inflammatory, immune
responses [48]. Theses bioactive molecules would in-
terfere with the initiation of host immune response.
On the other hand, vaccine targeting concealed anti-
gen could not be interfered by the bioactive molecules
[55,93]. However, repeated immunizations are required
for maintaining the adequate levels of immunity. Basi-
cally, host immunoglobulines likely to interact with
not only gut-derived antigens but also organs/tissues,
because it is well known that host immunoglobulines
pass though the midgut into hemocoel [20,83]. As a
result of immunoglobulin passage into the body ca-
vity, rapture/interference of the target molecules would
occur.
2. Vaccine development using exposed antigens
Several exposed antigens have been expres-
sed as recombinant proteins so far, and evaluated its
efficacy for anti-tick vaccine (Table 1). The way to
explore the exposed antigens is proceeding at the mole-
cular level. Among various kinds of molecular bio-
logical techniques, immunoscreening analysis, using
negitnA seicepSkciT noitaziretcarahC ytreporP .feR
P46 sutalucidneppa.R nietorptnemeC delaecnochtiwgnitcaer-ssorC
seicepskcittnereffiddnasnegitna ]67[
92p sinrocignol.H nietorptnemeC segatskcitllatsniagaevitceffE ]54[
43LH sinrocignol.H nietorptnemeC dnalahpmyntsniagaevitceffE
skcittluda ]77[
63MIR sutalucidneppa.R nietorptnemeC elttactsniagaevitcetorptoN ]6[











nietorpgnidnib-enimatsiH sutalucidneppa.R gnidnib-enimatsiH aeniugninoitcaeresrevdA ledomgip ]85[
Table 1. Representative exposed antigens evaluated as recombinat anti-tick vaccines.
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host sera from the host repeatedly fed by ticks, has
been mainstay to explore exposed antigen. Because
this method is theoretically supported by the fact that
the antigen that could be screened is really exposed
into host during feeding and immunogenic. While
some of them are established as the effective antigen,
no recombinant antigen has been developed commer-
cially.
Immunoscreening of a partially fed adult fe-
male cDNA library of H. longicornis, using antiserum
from a rabbit repeatedly fed with the tick, identified
the p29 and HL34 of putative cement protein [45,77].
Immunization of rabbits with recombinant p29 lead
to 40% and 56% mortality in larval and nymphal ticks,
respectively, and a 17% reduction in engorgement
weight of adult ticks. Efficacy of tick cement as vac-
cine antigens have been supported by several works
[76,97]. On the other hand, RIM36, an immunodominant
cement cone protein of R. appendiculatus induced a
strong antibody response in tick-exposed cattle, but
no protective immune response was induced by RIM36
[6]. Immunodominancy might be distinguished from
protective immune response in principle. Among seve-
ral exposed antigens, 64P showed unique characteris-
tics, and was identified by random screening of cDNA
library derived from pooled male and female sali-
vary glands of ticks [76]. Though 64P is originally
cloned as exposed antigen, it could be reactive with
internal tissues, suggested that 64P possess more than
one conserved antigenic epitope. Moreover challenge
experiment using guinea pig model, recombinant 64P
immunization is cross protective against different tick
stages and species, causing mortality of up to 80%.
Except for the cement molecules described above, his-
tamine-binding protein [58], immunoglobline-binding
protein [86] and calreticulin [15,31] from salivary gland
were evaluated for the candidate vaccine. For exam-
ples, calreticulin, which is a calcium binding protein
normally found in endoplasmic reticulum, was secre-
ted in tick saliva, and was firstly identified in a cDNA
library of partially fed female Amblyomma americanum
salivary glands. In a rabbit model, immunization with
recombinant A. americanum calreticulin caused necro-
tic cutaneous lesions on tick challenge. Though sera
collected from the dog fed by R. appendiculatus recog-
nized recombinant B. microplus calreticulin, the re-
combinat did not induce an antibody response in cattle.
This phenomenon might be caused by the genetic con-
servation of carleticulin between the host and tick.
While vaccine development using exposed
antigens would have some difficulties as described
before, the cement proteins are possible candidates
for the further assessment in cattle trials.
3. Vaccine development using concealed antigens
As hidden from the host immune system, the
vaccine candidate molecules derived from tick inter-
nal tissues/organs are so called as concealed antigen
(Table 2). Originally, the concept of using concealed
antigens to immunize the hosts against ticks was based
negitnA seicepSkciT noitaziretcarahC ytreporP .feR
68mB sulporcim.B noitcnufnwonknu;nietorptuG eniccavlaicremmoC ]29[
59mB sulporcim.B noitcnufnwonknu;nietorptuG tnairavecneuqes68mB ]22[
19mB sulporcim.B esaditpepidyxobraC caciffedesaercnI ]66[
7AMB sulporcim.B enarbmemekil-nicuM caciffedesaercnI ]24[
03/72P sinrocignol.H nietorpekil-IninoporT ledomecimnignideefkcitsriapmI ]69[
snipreS sinrocignol.H srotibihniesaetorpenireS dnalahpmyntsniagaevitceffE ledomtibbarniskcittluda ]52,07[








Table 2. Representative concealed antigens evaluated as recombinat anti-tick vaccines.
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on the idea of inducing antibody targeting tick mole-
cules that play essential functions. Therefore, in order
to explore the effective antigen, molecular identifica-
tion, characterization, cloning and generation of recom-
binant protein is necessary to evaluate the vaccine
efficacy. The mechanism why antibody against inter-
nal molecules in ticks would be effective is explained
as follows. Because it is well known the fact that anti-
body could pass intact through the midgut into hemo-
lymph [36], and then might be move to the each inter-
nal organ. Therefore the antibodies would induce a dis-
ruption of the essential functions and kill the feeding
ticks and the engorged ticks. Work on the develop-
ment of recombinant vaccines against cattle tick B.
microplus represents one of the most significant advan-
ces to date in the use of concealed antigens to immu-
nize cattle against ticks. Three concealed antigen, Bm86
[94], Bm91 [66] and BMA7 [42] have been identified
from gut wall of the cattle tick Boophilus micloplus.
Especially, vaccine based on Bm 86 became the first
ever anti-arthropod vaccine commercially available
[74]. Bm91 and BMA7 were later identified to enhance
the efficacy of the BM86-based vaccine. The anti-
tick effect induced by either Bm91 or BMA7 alone
was strikingly less effective, when compared to that
induced by recombinant Bm86 alone. However when
either of the two antigens (BM91 or BMA7) was used
in a cocktail with Bm86, anti-tick immunity induced
by the cocktail was much more efficient than that ob-
served with the commercial vaccine [42,95]. Tick gut
wall antigens interact with specific immunoglobulins
taken up in the blood meal from the immunized host,
and then antibody binding potentially causes lysis of
the gut wall, interfering with digestion of the blood
and subsequent egg production [1,20]. The strong anti-
body responses are injurious to adult tick survival,
though it is short lived [92]. Because the Bm86 antigen
is normally hidden from host immune system, natu-
ral infestation does not boost an immune response.
Vaccination may be required at 6-month interval to
sustain the immunity [13]. One of the most significant
observations from the work on a vaccine against tick
gut is the fact that Bm86 provides the proof of con-
cept for anti-tick vaccines. However anti-tick vaccines
for other major tick species are not still being practical.
Except for gut-derived molecule, several antigens from
various tissues have been expressed as recombinant
and evaluated as vaccine candidates.
A recombinant prepared from a P27/30 tropo-
nin I like protein of H. longicornis, is abundantly ex-
pressed in muscle, induce a protective immunity in
mice model. It demonstrated the prolonged pre-feeding
period of adult ticks and reduced attachment rate of
larval ticks [96].
Immunization of sheep with 4D8, a 21-kDa
putative soluble cytoplasmic protein of Ixodes scapularis,
reduced infestation levels, prolonged engorgement and
resulted in smaller egg masses of adult I. scapularis.
Subolesin (4D8) was recently discovered in I. scapu-
laris by expression library immunization (ELI) in com-
bination with sequence analysis of expressed sequence
tags (ESTs) in a mouse model of larval infestations.
Subolesin, a highly conserved protein involved in mo-
dulation of tick feeding and reproduction, was pro-
tective against all tick developmental stages when used
in cDNA and/or recombinant protein immunization
experiments [3]. Analysis of subolesin DNA and pro-
tein sequences in 11 ixodid tick species has demons-
trated identity/similarity between 65%-97% and 60%-
98%, respectively. Furthermore, homologues of tick
subolesin were identified in other organisms ranging
from nematodes to humans. Taken these facts into con-
sideration, subolesin might be a candidate conserved
tick-protective antigen that could be used in vaccine
formulations for the control of multiple tick species.
Preliminary experiments using the recombinant I.
scapularis subolesin have shown a protective effect
against Dermacentor variabilis and A. americanum.
These results provide preliminary data on the feasibi-
lity of controlling infestations by multiple tick species
using conserved protective antigens [11]. Together with
the 64P, 4D8 is the suitable candidate for the universal
vaccine.
Voraxine is a male specific protein from the
gonads of A. hebraeum, induced during feeding [86].
At the result of immunization of rabbits with voraxine,
normal engorgement of mated female A. hebraeum
was impaired. Basically, it could be expected that targe-
ting gonad-associated protein would have some possi-
bility to affect the reproduction of ticks. This could be
a new concept with great impact, because interference
of the reproduction directly leads to the reduction of
second generation.
4. Serine protease inhibitors
While emerging the fact that serine protease
inhibitors belong to either exposed or concealed anti-
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gens, I have discussed the utility of serine protease
inhibitors, separately from the chapters introduced
above. First of all, general information of serine pro-
tease inhibitors is provided in this chapter.
In vertebrates, serine proteases have been well
studied to play an important role in regulation of seve-
ral physiological functions such as blood coagulation,
fibrinolysis, complement activation and tissue mode-
ling [32,62,67]. In invertebrates, these proteases are invol-
ved in fundamental physiological roles like the limu-
lus hemolymph clotting cascade [29,30], innate immune
response [28], molting and prophenoloxidase cascade
[32,33]. All serine proteases are usually regulated by
endogenous protease inhibitors with the target cano-
nical binding loop, which interact with the target en-
zyme active loop [7]. Based on the primary and three-
demensional structures of the protease inhibitors, they
are classified into at least 18 families [38]. Among them,
the following six families: Kazal, BPTI-Kunitz, ?-
Macroglobulin, Serpin, Pacifastin and Bombyx have
been identified from hemolymph and saliva in inverte-
brates [32,61,68]. Especially in hematophagous arthro-
pods, serine protease inhibitors, which belong to BPTI-
Kunitz, are mainly active toward thrombin and factor
Xa, the two key enzymes of blood coagulation cas-
cades [10].
As mentioned previously, one approach to eva-
luate exposed/concealed antigens as vaccine candi-
dates is to target molecules involved/contributed in key
physiological functions. Therefore, serine protease
inhibitors are theoretically thought to have potential
as antigen targeting tick homeostasis, and intensive
efforts had been done to explore serine protease inhi-
bitors for application of vaccine trial. Among tick spe-
cies, serine protease inhibitors belong to BPTI-Kunitz,
Serpin and small molecules (not categorized yet) have
been discovered so far. Representative serine protease
inhibitors, which have previously been cloned, were
introduced in this chapter.
4.1 BPTI-kunitz family derived from ticks
Ticks are rich source of serine protease inhi-
bitors, which belong to the BPTI-kunitz type family.
The BPTI-kunitz fold (basic trypsine inhibitor fold) is
characteristics of a family of serine protease inhibi-
tors. These inhibitors are polypeptides (< 65 residues)
with 6 cysteines arranged in a characteristics disul-
fide bond [39]. The basic structure consists of an N-
terminal 310-helix around the first cystein, a central
double stranded anti-parallel ?-sheet linked by a hair-
pin loop and a C-terminal three turn a-helix. Several
proteins with the BPTI-kunitz fold have been identi-
fied in tick saliva, and speculated as inhibitor of host
coagulation cascade during their feeding (Table 3).
Tick anti-coagulant peptide (TAP) and fXaI, as well
as ornithodorin and savignin (Thrombin inhibitors)
have been well studied for the soft ticks, M. moubata
and Ornithodoros savignyi, respectively [23,51,81,85].
As ixodid ticks are responsible for the transmission of
tick borne diseases, many studies have also been per-
formed using different stages of these species. BmTI
have been identified from larva of the hard tick B.
microplus that inhibit trypsin, elastase and kallikrein
[72]. Ixolaris have been reported as the fVII/tissue factor
complex inhibitor with double-domain BPTI-like pro-
tein [19]. The random sequence analysis of expression
tagged cDNA library revealed that the proteins be-
emaN seicepS tegraT )aDk(rM tnemirepxeeniccaV .feR
skcittfoS
PAT atabuom.O aXf 7 - ]58[
nirdohtinro atabuom.O nibmorhT 21 - ]18[
IaXf iyngivas.O aXf 7 - ]32[
ningivas iyngivas.O nibmorhT 21 - ]15[
skcitdraH
ITmB sulporcim.B nierkillaK 81 lavraltsniagaevitceffE ledomelttacniskcit ]27,4[
siraroxI siralupacs.I FT-aIIVF 61 - ]91[
Table 3. Representative molecules derived from ticks, which belongs to BPTI-kunitz family.
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long to this family is mainly contained in tick saliva,
and targeted toward host blood coagulation factor.
4.2 Serpin
Approximately 500 serpins have been iden-
tified in a large variety of species so far. In human
plasma, they make up approximately 2% of the total
protein amount, of which 70% is a -1-antitrypsine. Both
extracellular and intracellular serpins are identified
[82]. Members of the superfamily of serine protease
inhibitors are expressed in a cell-specific manner and
are involved in a number of fundamental biological
process such as blood coagulation, complement acti-
vation, fibrinolysis, angiogenesis, inflammation and
tumor suppression [10,67]. On average, serpins are 350-
400 amino acids long. The protein structure of serpins
is usually characterized by 3 b -sheets, and 8 or 9 a -
helices. Typically, the future of serpins is the reactive
center loop (RCL), which is the motif composed of
approximately 20 amino acids, located near the C-
terminal end of the protein. The RCL contains a scis-
sile bond between amino acid residues called P1 and
P1’, which is cleaved by the target protease. Once clea-
ved, the RCL domain traps the target protease and
moves to the opposite pole of the serpin through the
b -sheet A. This association results in an irreversible
loss of structure and distortion of both protease and
the serpin. The hinge region inside the RCL (amino
acids P15-P9) is implicated in the stabilization of the
interaction with the protease and provides mobility for
the integration of the RCL in b -sheet A. Some serpin
family members, while structurally similar to serpins,
have no inhibitory activities. These non-inhibitory ser-
pins include ovalbumin, gene Y protein, hormone bin-
ding protein, corticosteroid binding globulin and thyro-
xine binding globulin. The serpins described above
are included either because extensive studies have been
failed to show inhibitory properties or they have been
only poorly characterized to date, with no demonstra-
tion of protease inhibition. And the RCL sequences
are either unusual for inhibitory serpins or thought to
contain residues inimical to the efficient operation of
the loop insertion mechanism.
A few serpins have been recently cloned from
the hard ticks B. microplus, H. longicornis, A. hebraeum,
A. variegatum, R. appendiculatus and I. scapularis
[27,35,46,70] (Table 5). Iris “Ixodes ricinus immunosu-
pressor” was found in the tick saliva, and related to
the pig leukocyte elastase inhibitor. Iris was demons-
trated to interfere with the coagulation pathways and
the fibrinolysis process via the RCL domain and with
platelet adhesion via another functional domain [40].
HLS1 “Haemaphysalis longicornis serpin 1” and HLS2
“Haemaphysalis longicornis serpin 2” were found in
the cDNAs constructed from tick midgut and hemo-
lymph, and related to the anti-thrombin III and the
Limulus intracellular coagulation inhibitor, respectively
[27,70]. Naïve HLS1 was not secreted into host during
the feeding, and mRNA transcripts were only detected
from the midgut. These results indicated that naïve HLS1
is not involved in the host defensive process stimu-
lated by tick feeding, but involved in the physiologi-
cal functions of ticks. On the other hands recombi-
nant HLS2 affected on activated partial thromboplastin
time (APTT), which is a screening assay for deficiency
of coagulation factors associated with intrinsic pathway.
However naïve HLS2 was not secreted into host. The
location where HLS2 expressed was hemolymph, sug-
gesting that naïve HLS2 is involved in the mainte-
nance of hemolymph circulation. Since the ticks are
likely to have a coagulation cascade like Limlus. Rhipi-
cephalus appendiculatus serpin-1, 2, 3 and 4 “RAS-1,
-2, -3 and -4” were also cloned from feeding tick [46].
Based on the sequence similarity of RAS-1, -2, -3 and
-4 with other known serpins, they are also thought to
be associated with physiological function of ticks.
However functional assay using recombinant protein
has never been done yet.
As considering the results introducing above,
tick serpins are mainly existed in tick internal organs,
and hidden from host except the report on Iris.
4.3 Small molecular weight serine protease inhibitors
Recently, Small molecules, which demonstra-
ted an inhibitory activity of serine protease, have been
cloned from hard tick Haemaphysalis longicornis
(Table 4). The proteins, named madanin 1 and 2, were
7-kDa proteins and showed no significant similarities
to any proteins previously identified [30]. Assays using
human plasma demonstrated that madanin 1 and 2
prolonged dose-dependently both activated partial
thromboplastin time and prothrombin time, indicating
that madanin 1 and 2 could inhibit the common path-
way of both intrinsic and extrinsic. Direct binding
assay demonstrated that madanin 1 and 2 specifically
interacted with thrombin. Furthermore, it was clearly
shown that madanin 1 and 2 inhibited conversion of
fibrinogen into fibrin by thrombin, thrombin-catalyzed
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activation of factor V and factor VIII, and thrombin-
induced aggregation of platelets without affecting
thrombin amidolytic activity. These results suggest
that madanin 1 and 2 bind to the anion-binding exosite
1 on the thrombin molecule, but not to the active cleft,
and interfere with the association of fibrinogen, factor
V, factor VIII and thrombin receptor on platelets with
an anion-binding exosite 1. They appear to be exosite
1-directed competitive inhibitors. Following the report
about madanin, novel thrombin inhibitor, named chi-
madanin, was also identified from the same tick [47].
In spite that chimadanin also showed no sequence simi-
larity with other anticoagulants, anti-coagulant pro-
perty and thrombin inhibitory activity were also obser-
ved by recombinant chimadanin.
Based on the fact that strategy toward anticoa-
gulation of host blood is necessitate to continuous
feeding of tick, anti-coagulant molecules in saliva
seems to be highly evolved beyond our knowledge.
Because information assembled from random sequence
analysis of cDNA library constructed from the sali-
vary glands during feeding included large number of
the sequences that have no significant homology to
other known molecules. It is natural to speculate that
these unknown molecules supposed to be involved in
the interference of host defensive process, since ticks
highly adapt to a blood-feeding environment [41].
4.4 Anti-tick vaccine trial using serine
protease inhibitors
A large number of vaccine candidates have
been expressed as recombinant proteins and tested
their suitability as vaccine candidates. In spite that se-
rine protease inhibitors have been expected as vaccine
antigen, the case reports evaluating serine protease
inhibitors for vaccine candidates have been a few. How-
ever the vaccine effects of serine protease inhibitors
against ticks have been actually observed in various
experimental models (Table 2, 4 and 5). Andreotti et
al [4] reported the immunization of host with a serine
protease inhibitor (BmTI), which belongs to BPTI-
Kunitz family, extracted from B. microplus larval ticks.
As judged from the small molecular weight of BmTI,
it is likely to be the component of tick saliva and could
be secreted into the host bite site during feeding. Bos
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Table 4. Serine protease inhibitor, which shows no significant similarities to any previously identified proteins.
emaN/.oN.ccA seicepS tnemirepxeeniccaV .feR
96422CAC siralupacs.I - -
81855BAC siralupacs.I - -
234213YA sulporcim.B - -
1SLH sinrocignol.H dnalahpmynfognideefretfadnagnirudetarytilatromdesaerecnI ledomtibbarniskcittluda ]07[










Table 5. Representative molecules derived from ticks, which belongs to Serpin family.
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indicus Nelore breed calves, previously sensitized with
BmTIs and challenged with tick larvae (20,000 larvae/
animal), showed 72.8% efficacy to interfere in tick deve-
lopment with 69.7% and 71.3% reduction of both tick
number and egg weight, respectively. Sugino et al [70]
and Imamura et al [27] reported the immunization of
rabbits with serine protease inhibitor (HLS1, HLS2),
respectively. HLS1 and HLS2 belong to Serpin family,
and were induced during blood feeding of H. longicor-
nis. Since the physiological role of HLS1 and HLS2
were postulated as a regulation of blood meal diges-
tion and maintenance of hemolymph circulation, res-
pectively, they have potential as an antigenic cocktail
targeting tick homeostasis. In rabbit model, vaccina-
tion with recombinant HLS1 and HLS2 actually resul-
ted in increased mortality of both nymphal and adult
ticks. In our other experiment [26], cocktail vaccine trial
using a combination of internal serpins (RAS-1and
RAS-2) also demonstrated increasing mortality of
nymphal ticks in cattle model. This could be a practi-
cal example for the utility of serpins as vaccine antigen
for field application.
The concept of using serpins to immunize
hosts against ticks was originally based on the idea
on inducing antibody against the tick molecules that
performed essential functions. In principle, uptake
of the antibodies via a blood meal would then dis-
rupt the essential functions and kill the feeding ticks
and engorged ticks. Just as described above, anti-
body against tick serine protease inhibitor also seems
to reach the place where naïve proteins are, and could
compromise the function of naïve protein. As a re-
sult of interference of naïve serine protease inhibitor,
unbalance of tick homeostasis would occur and result
in prolonged feeding and increased mortality. Based
on the results introduced above, serine protease inhi-
bitor could be an important molecule to advance in
anti-tick vaccine development.
5. Future challenge – optimal tick vaccine
Though recombinant vaccines derived from
cement, gut and serine protease inhibitor were asses-
sed for their vaccine efficacy and demonstrated suc-
cessful immunization on several kind of experimental
animals, further exploring and characterization of can-
didates should be done for development of ideal vac-
cine. Application of the molecular biological techni-
ques and genome informatics tool has great impact
for the research on ixodid ticks with valuable results
for tick vaccine development. Because it is clear that
the advances for optimal vaccines against ticks requi-
res well understanding of basic tick physiology. Cons-
traction of expressed sequenced tag databases has been
reported for B. microplus [9], A. americanum [25], A
variegatum [50] and R. appendiculatus [49]. The trans-
criptome of tick salivary glands has been characterised
in I. scapularis [79], I. ricinus [78], I. pacificus [18], A.
americanum, D. andersoni [5] and H. longicorni [48].
The gathering sequence informations in tick species
have to be used for functional analysis in order to
annotate and select vaccine candidate. To achive this
object, RNAi has been applicable for rapid analysis
of systematic function. Because RNAi has been one of
the most promising technologies for manipulating gene
expression of target molecules where other genetic
tools are not available. Therefore RNAi contributes to
the rapid selection for the candidates based on the
function of the target protein. On the other hand, even
if systematic function of the molecules was not known
or revealed, it could be potential candidate as long as
it demonstrate the vaccine efficacy. Namely, to de-
fine the funciton of candidate is important but not essen-
tial, because the most considerable thing in the aspect
of vaccine development is whether the antigen of in-
terset could induce protective imunity or not. Expres-
sion library immunization (ELI) has a potential to
explore the canditdate antigen efficiently, because the
basis of ELI is dependent on the immunogenicity and
induction of protective immunity. If it were combined
with sequence anlysis of ESTs, ELI would support to
find out both the promising candidate antigen and its
putative function coincidently. The application of these
technology to explore potential candidates could im-
pact on tick vaccine development through the identifi-
cation and characterization of tick-protective antigens.
Recent years, here emerged critical examples
that have an insight into the advance of ideal condi-
tions of anti-tick vaccine. The novel concept listed in
this chapter would not be ignored for the development
of anti-tick vaccine.
5.1 Tick vaccine against multiple tick species
A broad-spectrum/universal vaccine is one
that targets not only all stages of ticks but also mul-
tiple tick species and ideally, all species. Highly conser-
ved antigens between tick species potentially possess
the properties for cross-resistance across all tick spe-
cies and stages. Early experiments using B. microplus
Bm86 demonstrated cross-protection against B. annu-
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latus and B. decoloratus infestations, and partial protec-
tion against Hyalomma and Rhipicephalus spp [12,14,
17]. However the protection against Ammblyomma spp
[14] and some geographical strains of B. microplus [21,
22] was failed by the immunization of Bm86. These
results supported the application of the Bm86 vacci-
nes were widely available in regions where Boophilus
spp. co-localized with other tick genera, as such fre-
quently occurs in regions of America, Africa and Asia.
Consideration of cross-resistance among different tick
genera is important for the broadest application of
vaccine. Trimnell et al [76] provided an example for
the broad-spectrum vaccine using the putative tick ce-
ment protein as target molecule. Because ixodid tick
species use cement to attach onto the host skin for
feeding, cement is potentially conserved among multi-
ple tick species. Based on this concept, they identified
the R. appendiculatus 64P antigen, which demonstra-
ted immune reactivity with R. sanguineus, I. ricinus,
A variegatum and B. microplus. 64P induced protec-
tive immunity against R. sanguineus and I. ricinus in
guinea pig model, which may be useful for control-
ling tick species with broad-spectrum. Subolesin (4D8)
was also discovered in I. scapularis by expression li-
brary immunization (ELI) in combination with se-
quence analysis of expressed sequence tag (ESTs) in a
mouse model of larval infestation [2]. Subolesin was
a protein with high sequence similarity among ixodid
tick species, and expected to be involved in a modu-
lation of tick feeding and reproduction. Immunization
of sheep with recombinant Subolesin induced protec-
tive immunity against adult I. scapularis [3]. These sup-
ported a possibility of using Subolesin for controlling
multiple tick species. As described previously, tick ser-
pins were also characterized as an effective antigen
with high conservation between ixodid tick species
[27,46,70]. For example, HLS2 was discovered from par-
tially fed H. longicornis by RACE method. Analysis
of the HLS2 suggested that the HLS2 likely to be invol-
ved in maintenance of hemolymph circulation during
feeding of ticks. Immunization of recombinant HLS2
with rabbit demonstrated increased mortality rate of
both nymphal and adult ticks. Since homologous mole-
cules with HLS2 were identified from R. appendiculatus,
B. microplus, HLS2 may be a candidate for a tick-
protective antigen that could be used in vaccine for-
mulations for the control of multiple tick species. To
develop the universal vaccine against tick species, it
is important to identify and characterize tick molecules
that are involved in a crucial function of tick, and are
commonly existed among broad range of tick species.
5.2 Dual action vaccine
One of the most different properties between
exposed and concealed antigen is whether repeated
immunization is required to maintain elevated anti-body
titers. Antibody titers induced by exposed antigens is
boosted naturally through the tick infestation, because
the target antigen is exposed to the host immune sys-
tem during tick infestation. On the other hand concea-
led antigens are hidden from host immune system,
therefore antibody titers are only maintained by repea-
ted immunization of the antigen. However the advan-
tages of using concealed antigens results from the
unlikely possibility that ticks would have evolved a
mechanism to effectively counteract the effect of the
host immune system as had occurred with exposed anti-
gens [93]. A recent study proposed new concept of
the vaccine that combine the advantages of both expo-
sed and concealed antigens. 64P, a 15 kDa protein from
R. appendiculatus, was identified as a putative cement
protein involved in attachment and feeding of tick.
Vaccination of guinea pigs with recombinant versions
of 64P protein resulted in 48% and 70% reduction of
the nymphal and adult infestation rates, respectively.
Interestingly, the immune response induced by this
exposed salivary antigen cross-reacted with concealed
tick gut antigens [76].
5.3 Transmission blocking vaccine
An important aspect of controlling tick infes-
tations is a reduction of the transmission of tick-borne
pathogens. Therefore anti-tick vaccines should reduce
the incidence of tick-borne diseases through reducing
vector numbers in principle. The phenomenon of re-
duced transmission capacity of ticks fed on immuni-
zed animal has been observed with several works. Early
experiments with Bm86 vaccines resulted in a reduc-
tion in the incidence of babesiosis together with a redu-
ced number of tick infestation [13,80]. In recent work
reported by Labuda et al [37], the transmission of tick
borne encephalitis virus (TBEV) was prevented by the
vaccination of the putative tick cement 64P in mice
model, suggesting that 64P could be a potential candi-
date for transmission-blocking vaccines.
In our current study (Imamura et al unpubli-
shed data), immunization of cattle with a combination
of recombinant serpin from R. appendiculatus indu-
ced a partial blocking of T. parva transmission via tick,
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quantified by Real-time PCR analysis. Though there
was no direct association between tick serpin and patho-
gen, compromising the tick physiology induced by
the immunization with serpin seemed to affect not only
on a tick feeding activity but also on a vector capacity
of ticks. Though these works mentioned above have
some efficacy against vector capacity of ticks, innova-
tive approach is needed to advance the transmission-
blocking vaccines. Because vaccines designed for tar-
geting anti-vector are required to distinguish antigens
that induce protective immunity against ticks while
preventing pathogen transmission.
There are only a few molecules, which have
been proved as direct association between tick vector
and the pathogen. Recent study by Pal et al [59] repor-
ted the identification of a tick receptor (TROSPA) that
was required for B. burgdorferi colonization of I. sca-
pularis. They demonstrated bacterial OspA was a ligand
for TROSPA and the blocking of TROSPA by TROSPA
antisera or by the repression of TROSPA expression
with RNA interference (RNAi) reduced adherence to
the I. scapularis gut in vivo. Following the discovery
of TROSPA, Gomes-Solecki et al [24] demonstrated
the reduction of Borrelia burgdorferi infection of I.
scaplaris fed on mice immunized with an oral vaccine
based in bacterial OspA, postulated by preventing bac-
terial adhesion to the tick receptor.
Ramamoorthi et al [63] reported that Salp15,
an Ixodes scapularis salivary protein, inhibited CD4+
T cell activation. Salp15 also inhibited the development
of CD4+ T cell-mediated immune responses in vivo,
demonstrating the functional importance of this pro-
tein. Salp15 provides a molecular basis for understan-
ding the immunosuppressive activity of I. scapularis
saliva and vector-host interactions. Interestingly, the
level of Salp15 expression was selectively enhanced
by the presence of B. burgdorferi in Ixodes scapularis,
first indicating that spirochaetes might use Salp15 du-
ring transmission. Salp15 was then shown to adhere
to the spirochaete, both in vitro and in vivo, and speci-
fically interacted with B. burgdorferi outer surface pro-
tein C. The binding of Salp15 protected B. burgdorferi
from antibody-mediated killing in vitro and provided
spirochaetes with a marked advantage when they were
inoculated into naive mice or animals previously infec-
ted with B. burgdorferi. Moreover, RNA interference-
mediated repression of Salp15 in I. scapularis drasti-
cally reduced the capacity of tick-borne spirochaetes
to infect mice. These results showed the capacity of
a pathogen to use a secreted arthropod protein to help
it colonize the mammalian host. Based on the results
descrived above, tick derived molecules like TROSPA
and Salp15 appear to be possible candidate for a patho-
gen blocking vaccine.
IV. CONCLUSION
Prior to recent advances in molecular biologi-
cal technology, the major limitation in this research
area was absence of a sustainable practical approach
to produce recombinant antigens in vitro for further
analysis. Now, this limitation has already been over-
come and therefore future studies should focus on
identification and characterization of tick proteins res-
ponsible for modulation of host immune response and
homeostasis as well as pathogen transmission. Once
recombinant molecules of interest are obtained, stu-
dies to clearly discern the molecular basis of these pro-
teins will be carried out. The outcome of theses studies
will provide fundamental information to explore and
develop effective tick vaccine applicable to field use.
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